- Global Pharma News & Resources

Anticoagulants Market: Revolutionizing Blood Clot Prevention and Treatment | Boehringer Ingelheim, Janssen Pharmaceuticals, Pfizer

Anticoagulants Market– Global Outlook and Forecast 2023-2030 is latest research study released by Allied Market Research evaluating the market risk side analysis, highlighting opportunities and leveraged with strategic and tactical decision-making support (2023-2030). The market Study is segmented by key a region that is accelerating the marketization. The report provides information on market research and development, growth drivers, and the changing investment structure of the Global Anticoagulants Market. Some of the key players profiled in the study are Aspen Holdings, Bayer AG, Boehringer Ingelheim, Bristol-Myers Squibb Company, Daiichi Sankyo Company, GlaxoSmithKline, Johnson & Johnson (Janssen Pharmaceuticals), Pfizer, Portola Pharmaceuticals, and Sanofi. The global Anticoagulants market is expected to reach $43,427 million by 2025, growing at a CAGR of 7.5% from 2018 to 2025.

Click To get FREE SAMPLE PDF (Including Full TOC, Table & Figures):

Anticoagulants Market Outlook 2020-2030

The anticoagulants market is divided into different drug classes, including NOACs, heparin & LMWH, vitamin K antagonists, and others. Currently, the NOACs segment is the primary revenue generator and is expected to maintain its dominance during the forecast period. This is due to the growing awareness and increased utilization of NOACs compared to warfarin. However, the higher price of NOACs poses a hindrance to market growth.

Regarding the route of administration, the anticoagulants market is segmented into oral anticoagulants and injectable anticoagulants. Currently, the oral anticoagulant segment holds a significant share of revenue and is projected to maintain its dominance in the forecast period. This can be attributed to the increasing adoption of NOACs and the wider availability of lower-cost warfarin.

In terms of application, the market is categorized into atrial fibrillation & heart attack, stroke, deep vein thrombosis (DVT), pulmonary embolism (PE), and others. Currently, the atrial fibrillation & heart attack segment is a major contributor to revenue and is expected to maintain its dominance throughout the forecast period. This is due to the large target population and the growing use of anticoagulants for the treatment of these conditions. However, the DVT segment is projected to exhibit the fastest market growth, driven by the increasing prevalence of DVT and advancements in its diagnosis technology.

Marketing Communication and Sales Channel

Understanding “marketing effectiveness” on a continual basis, help determine the potential of advertising and marketing communications and allow to use of best practices to utilize untapped audience. In order to make marketers make effective strategies and identify why the target market is not giving attention, we ensure the Study is Segmented with appropriate marketing & sales channels to identify potential market size by value & Volume* (if Applicable).

Have Any Query? Ask Our Expert @:

The segments and sub-section of Anticoagulants market is shown below:

By Drug Class: NOACs, Heparin & LMWH, Vitamin K Antagonist, and Others

By Route of Administration: Oral Anticoagulant and Injectable Anticoagulant

By Application: Atrial Fibrillation & Heart Attack, Stroke, Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), and Others

Some of the key players involved in the Market are: Aspen Holdings, Bayer AG, Boehringer Ingelheim, Bristol-Myers Squibb Company, Daiichi Sankyo Company, GlaxoSmithKline, Johnson & Johnson (Janssen Pharmaceuticals), Pfizer, Portola Pharmaceuticals, and Sanofi.

Important years considered in the Anticoagulants study:

Historical year – 2017-2021; Base year – 2021; Forecast period** – 2022 to 2030 [** unless otherwise stated]

If opting for the Global version of Anticoagulants Market; then below country analysis would be included:

– North America (USA, Canada and Mexico)

– Europe (Germany, France, the United Kingdom, Netherlands, Italy, Nordic Nations, Spain, Switzerland and Rest of Europe)

– Asia-Pacific (China, Japan, Australia, New Zealand, South Korea, India, Southeast Asia and Rest of APAC)

– South America (Brazil, Argentina, Chile, Colombia, Rest of countries etc.)

– Middle East and Africa (Saudi Arabia, United Arab Emirates, Israel, Egypt, Turkey, Nigeria, South Africa, Rest of MEA)

Introduction about Anticoagulants Market

Anticoagulants Market Size (Sales) Market Share by Type (Product Category)

Anticoagulants Market by Application/End Users

Anticoagulants Sales (Volume) and Market Share Comparison by Applications

Global Anticoagulants Sales and Growth Rate (2020-2030)

Anticoagulants Competition by Players/Suppliers, Region, Type, and Application

Anticoagulants (Volume, Value, and Sales Price) table defined for each geographic region defined.

Anticoagulants Players/Suppliers Profiles and Sales Data

Key Raw Materials Analysis & Price Trends

Supply Chain, Sourcing Strategy and Downstream Buyers, Industrial Chain Analysis

……..and view more in complete table of Contents

Procure Complete Report (220+ Pages PDF with Insights, Charts, Tables, and Figures) @

Thanks for reading this article; you can also get an individual chapter-wise sections or region-wise report versions like North America, LATAM, Europe, or Southeast Asia.

Read More Trending Reports Here:

Blood Plasma Derivatives Market by Product Type (Albumin, Anti-inhibitor Coagulation Factor, Factor VIII, Factor IX Concentrate, Immunoglobulins, Rh Immunoglobulin, Alpha 1-Protaese Inhibitor, and Anti-Thrombin), Application (HIV, Hemophilia A, Hemophilia B, Hepatitis C, Bleeding Disorders, Genetic Lung Disorders, Immune Deficiency System, Liver Conditions, and Viral Disease), and End User (Hospital, Clinic, Transfusion Center, and Others): Global Opportunity Analysis and Industry Forecast, 2021-2030

IVF Services Market by Cycle Type (Fresh IVF Cycles (Non-donor), Thawed IVF Cycles (Non-donor), and Donor Egg IVF Cycles) and End User (Fertility Clinics, Hospitals, Surgical Centers, and Clinical Research Institutes): Global Opportunity Analysis and Industry Forecast, 2021-2030

Cell Expansion Market by Product (Consumable and Instrument), Application (Stem Cell Technology, Cancer Research, Drug Screening & Development, Tissue Engineering & Regenerative Medicine, and Others), and End User (Research Institutes, Pharmaceutical & Biotechnology Companies, and Others): Global Opportunity Analysis and Industry Forecast, 2021-2030

About Us:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.

Contact Us:

David Correa

Portland, OR, United States

USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022,

UK: +44-845-528-1300

Hong Kong: +852-301-84916

India (Pune): +91-20-66346060

Fax: +1(855)550-5975


Editor Details

  • Company:
    • The Wire Times
Last Updated: 19-May-2023